Evidence map›Paper›PMID 36788501›Full record

ArticleBMC cancer2023

Single-copy Snail upregulation causes partial epithelial-mesenchymal transition in colon cancer cells.

Fatima Junaid, Goran Tomic, Richard Kemp, Doug J Winton

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Fatima JunaidCancer Research UK - Cambridge Institute, University of Cambridge, Cambridge, CB2 0RE, UK. fatima.junaid@nhs.net.ORCID http://orcid.org/0000-0003-2525-179X
Goran TomicCancer Research UK - Cambridge Institute, University of Cambridge, Cambridge, CB2 0RE, UK.
Richard KempCancer Research UK - Cambridge Institute, University of Cambridge, Cambridge, CB2 0RE, UK.
Doug J WintonCancer Research UK - Cambridge Institute, University of Cambridge, Cambridge, CB2 0RE, UK.
University of Cambridge · GB

Funding

Cancer Research UK 24456
6 · The paper itself

Abstract

backgroundEpithelial-mesenchymal transition (EMT) is an embryonic programme implicated in cancer stem cells, metastasis and therapeutic resistance. Its role in cancer progression remains controversial because the transition can be partial or complete in different models and contexts.

methodsUsing human colon cancer DLD-1 cells, we engineered a cell line with a single-copy of Snail that was doxycycline-inducible and compared it to existing EMT models in DLD-1. The effect of Snail upregulation was characterised functionally, morphologically, and by transcriptional profiling and protein expression.

resultsInduction with doxycycline increased Snail expression to a level similar to that observed in cancer cell lines spontaneously expressing Snail and results in partial EMT. In comparison, higher levels of overexpression arising from introduction of episomal-Snail, results in complete EMT. DLD-1 cells with partial EMT show chemoresistance in vitro, increased tumour growth in vivo and decreased apoptosis.

conclusionsThese findings highlight that the amount of bioavailable Snail can dictate phenotypic outcome and that partial EMT may be a preferred outcome of models operating within a natural range of Snail overexpression.

Indexed as

Colonic NeoplasmsEpithelial-Mesenchymal TransitionSnail Family Transcription FactorsCell Line, TumorCell MovementDoxycyclineHumansUp-RegulationDoxycyclineSNAI1 protein, humanSnail Family Transcription FactorsEpithelial-mesenchymal transitionMetastasisPartial transitionSNAIL

Identifiers

PMID36788501
PMCPMC9926732
OpenAlexW4320733291

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.